Niagen Bioscience (NAGE) Divestments (2013 - 2026)
Niagen Bioscience (NAGE) posted quarterly Divestments of $5.8 million for Q1 2026, up 215.1% quarter-over-quarter from $1.8 million in Q1 2015.
Powered by 
Analysis
Niagen Bioscience (NAGE) Divestments (2013 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has reported Divestments for 3 consecutive years, with $5.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Divestments changed N/A year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $8.1 million (changed N/A YoY), while the FY2015 annual figure was $1.8 million, changed N/A from the prior year.
- Divestments improved to $5.8 million in Q1 2026 per NAGE's latest filing, from $1.8 million in the prior quarter.
- Across five years, Divestments topped out at $5.8 million in Q1 2026 and bottomed at $5.8 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Niagen Bioscience | 251.05 Mn | 184.31 Mn | 19.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.80 Mn |
| Jan 2, 2016 | -1.09 Mn |
| Mar 30, 2013 | 500,000.00 |